SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (6533)5/10/1999 10:40:00 AM
From: VLAD  Read Replies (1) of 7041
 
Dale,

Yes, I would expect that bad news about the so called competition would move the price of Vivus higher but as I said before, I report the news and try not to make any timing or stock price predictions(since with a stock as manipulated as Vivus is I know better) although I firmly believe that Vivus is grossly under valuated. But I am also confident that in the longer run Vivus will do well based on future marketing deals and development of products currently in R&D. A new CEO would also be a very good omen.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext